Continuous-Time Learning of Probability Distributions: A Case Study in a Digital Trial of Young Children with Type 1 Diabetes

• URL: http://arxiv.org/abs/2603.24427v1
• Date: Wed, 25 Mar 2026 15:36:03 GMT
• Title: Continuous-Time Learning of Probability Distributions: A Case Study in a Digital Trial of Young Children with Type 1 Diabetes
• Abstract summary: Changes in the distribution of glucose measurements can reveal patterns of disease progression and treatment response.<n>Motivated by a 26-week clinical trial comparing the closed-loop insulin delivery system t:slim X2 with standard therapy in children with type 1 diabetes, we propose a probabilistic framework to model the continuous-time evolution of time-indexed distributions.
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Understanding how biomarker distributions evolve over time is a central challenge in digital health and chronic disease monitoring. In diabetes, changes in the distribution of glucose measurements can reveal patterns of disease progression and treatment response that conventional summary measures miss. Motivated by a 26-week clinical trial comparing the closed-loop insulin delivery system t:slim X2 with standard therapy in children with type 1 diabetes, we propose a probabilistic framework to model the continuous-time evolution of time-indexed distributions using continuous glucose monitoring data (CGM) collected every five minutes. We represent the glucose distribution as a Gaussian mixture, with time-varying mixture weights governed by a neural ODE. We estimate the model parameter using a distribution-matching criterion based on the maximum mean discrepancy. The resulting framework is interpretable, computationally efficient, and sensitive to subtle temporal distributional changes. Applied to CGM trial data, the method detects treatment-related improvements in glucose dynamics that are difficult to capture with traditional analytical approaches.

Related papers

• GlucoFM-Bench: Benchmarking Time-Series Foundation Models for Blood Glucose Forecasting [6.427581905332425]
  We present GlucoFM-Bench, a benchmark evaluating state-of-the-art foundation models for blood glucose forecasting.<n>We assess eight representative architectures, including pre-trained TSFMs, time-series large language models, and task-specific deep learning models.<n>Across datasets, pre-trained TSFMs show strong zero-shot and few-shot transfer, with the best zero-shot model performing within 5% of the best full-shot supervised model.
  arXiv  Detail & Related papers  (2026-06-05T03:49:26Z)
• Integrating Neural Differential Forecasting with Safe Reinforcement Learning for Blood Glucose Regulation [51.12307713554633]
  TSODE is a safety-aware controller that integrates Thompson RL Sampling with a Neural Ordinary Differential Equation forecaster.<n>In the FDA-approved UVa/Padova simulator (adult cohort), TSODE achieved 87.9% time-in-range with less than 10% time below 70 mg/dL.
  arXiv  Detail & Related papers  (2025-11-16T02:11:33Z)
• Conditional Neural ODE for Longitudinal Parkinson's Disease Progression Forecasting [51.906871559732245]
  Parkinson's disease (PD) shows heterogeneous, evolving brain-morphometry patterns.<n>Modeling these longitudinal trajectories enables mechanistic insight, treatment development, and individualized 'digital-twin' forecasting.<n>We propose CNODE, a novel framework for continuous, individualized PD progression forecasting.
  arXiv  Detail & Related papers  (2025-11-06T20:16:33Z)
• Continuous Temporal Learning of Probability Distributions via Neural ODEs with Applications in Continuous Glucose Monitoring Data [0.0]
  We introduce a probabilistic model based on a Gaussian mixture that captures the evolution of a continuous-time process.<n>We illustrate the broad utility of our approach in a 26-week clinical trial that treats all continuous glucose monitoring (CGM) time series as the primary outcome.
  arXiv  Detail & Related papers  (2025-05-13T15:57:06Z)
• A Large Sensor Foundation Model Pretrained on Continuous Glucose Monitor Data for Diabetes Management [3.8195320624847833]
  We introduce CGM-LSM, a Transformer decoder-based Large Sensor Model (LSM) pretrained on 1.6 million CGM records from patients with different diabetes types, ages, and genders.<n>We model patients as sequences of glucose time steps to learn latent knowledge embedded in CGM data and apply it to the prediction of glucose readings for a 2-hour horizon.<n>Compared with prior methods, CGM-LSM significantly improves prediction accuracy and robustness: a 48.51% reduction in root mean square error in one-hour horizon forecasting and consistent zero-shot prediction performance across held-out patient groups.
  arXiv  Detail & Related papers  (2024-12-12T21:35:13Z)
• From Glucose Patterns to Health Outcomes: A Generalizable Foundation Model for Continuous Glucose Monitor Data Analysis [47.23780364438969]
  We present GluFormer, a generative foundation model for CGM data that learns nuanced glycemic patterns and translates them into predictive representations of metabolic health.<n>GluFormer generalizes to 19 external cohorts spanning different ethnicities and ages, 5 countries, 8 CGM devices, and diverse pathophysiological states.<n>In a longitudinal study of 580 adults with CGM data and 12-year follow-up, GluFormer identifies individuals at elevated risk of developing diabetes more effectively than blood HbA1C%.
  arXiv  Detail & Related papers  (2024-08-20T13:19:06Z)
• Toward Short-Term Glucose Prediction Solely Based on CGM Time Series [4.7066018521459725]
  TimeGlu is an end-to-end pipeline for short-term glucose prediction based on CGM time series data. It achieves state-of-the-art performance without the need for additional personal data from patients.
  arXiv  Detail & Related papers  (2024-04-18T06:02:12Z)
• Machine Learning based prediction of Glucose Levels in Type 1 Diabetes Patients with the use of Continuous Glucose Monitoring Data [0.0]
  Continuous Glucose Monitoring (CGM) devices offer detailed, non-intrusive and real time insights into a patient's blood glucose concentrations. Leveraging advanced Machine Learning (ML) Models as methods of prediction of future glucose levels, gives rise to substantial quality of life improvements.
  arXiv  Detail & Related papers  (2023-02-24T19:10:40Z)
• SurvLatent ODE : A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Deep Vein Thrombosis (DVT) prediction [68.8204255655161]
  We propose a generative time-to-event model, SurvLatent ODE, which parameterizes a latent representation under irregularly sampled data. Our model then utilizes the latent representation to flexibly estimate survival times for multiple competing events without specifying shapes of event-specific hazard function. SurvLatent ODE outperforms the current clinical standard Khorana Risk scores for stratifying DVT risk groups.
  arXiv  Detail & Related papers  (2022-04-20T17:28:08Z)
• STELAR: Spatio-temporal Tensor Factorization with Latent Epidemiological Regularization [76.57716281104938]
  We develop a tensor method to predict the evolution of epidemic trends for many regions simultaneously. STELAR enables long-term prediction by incorporating latent temporal regularization through a system of discrete-time difference equations. We conduct experiments using both county- and state-level COVID-19 data and show that our model can identify interesting latent patterns of the epidemic.
  arXiv  Detail & Related papers  (2020-12-08T21:21:47Z)
• Short Term Blood Glucose Prediction based on Continuous Glucose Monitoring Data [53.01543207478818]
  This study explores the use of Continuous Glucose Monitoring (CGM) data as input for digital decision support tools. We investigate how Recurrent Neural Networks (RNNs) can be used for Short Term Blood Glucose (STBG) prediction.
  arXiv  Detail & Related papers  (2020-02-06T16:39:44Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.